Liaoning Wohua Kangchen Pharmaceutical

Liaoning Wohua Kangchen Pharmaceutical is a specialized pharmaceutical manufacturing and development company based in Benxi, China, operating as a key subsidiary of Beijing Kangchen Pharmaceutical. The company is primarily recognized for its production of Suling (Hemocoagulase Agkistrodon), a high-purity biochemical drug derived from snake venom used to control bleeding in surgical settings. Its manufacturing facilities are located in the Benxi High-tech Industrial Development Zone and are designed to meet international GMP standards for both biochemical and chemical drugs. Beyond its flagship hemostatic product, the company supports the parent organization's broader research and development efforts in the fields of oncology and hematology. Liaoning Wohua Kangchen plays a critical role in the supply chain and commercialization strategy for innovative therapies within the Chinese healthcare market.